Atomic level rendering of DNA-drug encounter

Biophysical Journal

Volumn 106, Issue 2, 2014, Pages 421-429

  Lucas, Maria F ^a   Cabeza De Vaca, Israel ^a   Takahashi, Ryoji ^a   Rubio Martínez, Jaime ^b   Guallar, Víctor ^a,c  

^a BARCELONA SUPERCOMPUTING CENTER   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DNA;

ARTICLE; CHEMISTRY; CONFORMATION; GENETICS; KINETICS; METABOLISM; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; THERMODYNAMICS;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CISPLATIN; DNA; KINETICS; MOLECULAR DYNAMICS SIMULATION; NUCLEIC ACID CONFORMATION; THERMODYNAMICS;

EID: 84892744682     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2013.11.4494     Document Type: Article

References (92)

1. M. Wilhelm, and A. Mukherjee R. Lavery Multistep drug intercalation: molecular dynamics and free energy studies of the binding of daunomycin to DNA J. Am. Chem. Soc. 134 2012 8588 8596
2. G.M. Torrie, and J.P. Valleau Nonphysical sampling distributions in Monte Carlo free-energy estimation: umbrella sampling J. Comput. Phys. 23 1977 187 199
3. Y. Deng, and B. Roux Calculation of standard binding free energies: aromatic molecules in the T4 lysozyme L99A mutant J. Chem. Theory Comput. 2 2006 1255 1273
4. M.S. Lee, and M.A. Olson Calculation of absolute protein-ligand binding affinity using path and endpoint approaches Biophys. J. 90 2006 864 877
5. I. Buch, T. Giorgino, and G. De Fabritiis Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations Proc. Natl. Acad. Sci. USA 108 2011 10184 10189
6. S.K. Sadiq, F. Noé, and G. De Fabritiis Kinetic characterization of the critical step in HIV-1 protease maturation Proc. Natl. Acad. Sci. USA 109 2012 20449 20454
7. Y. Shan, and E.T. Kim D.E. Shaw How does a drug molecule find its target binding site? J. Am. Chem. Soc. 133 2011 9181 9183
8. R.O. Dror, and R.M. Dirks D.E. Shaw Biomolecular simulation: a computational microscope for molecular biology Annu. Rev. Biophys. 41 2012 429 452
9. B. Rosenberg, L. Vancamp, and T. Krigas Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode Nature 205 1965 698 699
10. B. Rosenberg, and L. VanCamp V.H. Mansour Platinum compounds: a new class of potent antitumour agents Nature 222 1969 385 386
11. R.B. Weiss, and M.C. Christian New cisplatin analogues in development. A review Drugs 46 1993 360 377 (Pubitemid 23292114)
12. R.A. Alderden, M.D. Hall, and T.W. Hambley The discovery and development of cisplatin J. Chem. Educ. 83 2006 728
13. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J. Clin. 62 2012 10 29
14. S.E. Sherman, and S.J. Lippard Structural aspects of platinum anticancer drug interactions with DNA Chem. Rev. 87 1987 1153 1181
15. T. Boulikas, and M. Vougiouka Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review) Oncol. Rep. 11 2004 559 595
16. D. Wang, and S.J. Lippard Cellular processing of platinum anticancer drugs Nat. Rev. Drug Discov. 4 2005 307 320 (Pubitemid 41130944)
17. N.J. Wheate, and S. Walker R. Oun The status of platinum anticancer drugs in the clinic and in clinical trials Dalton Trans. 39 2010 8113 8127
18. J. Reedijk Improved understanding in platinum antitumour chemistry Chem. Commun. 7 1996 801 806 (Pubitemid 26119541)
19. E.R. Jamieson, and S.J. Lippard Structure, recognition, and processing of cisplatin-DNA adducts Chem. Rev. 99 1999 2467 2498
20. S.J. Lippard New chemistry of an old molecule: cis-[Pt(NH3)2Cl2] Science 218 1982 1075 1082 (Pt(NH3)2Cl2)
21. J.M. Pascoe, and J.J. Roberts Interactions between mammalian cell DNA and inorganic platinum compounds. I. DNA interstrand cross-linking and cytotoxic properties of platinum(II) compounds Biochem. Pharmacol. 23 1974 1359 1365
22. D.P. Gately, and S.B. Howell Cellular accumulation of the anticancer agent cisplatin: a review Br. J. Cancer 67 1993 1171 1176 (Pubitemid 23172848)
23. S. Ishida, and J. Lee I. Herskowitz Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals Proc. Natl. Acad. Sci. USA 99 2002 14298 14302 (Pubitemid 35257666)
24. S.E. Miller, and D.A. House The hydrolysis products of cis-diamminedichloroplatinum(II). I. The kinetics of formation and anation of the cis-diammine(aqua)chloroplatinum(II) cation in acidic aqueous solution Inorg. Chim. Acta 161 1989 131 137
25. Y. Zhang, Z. Guo, and X.-Z. You Hydrolysis theory for cisplatin and its analogues based on density functional studies J. Am. Chem. Soc. 123 2001 9378 9387 (Pubitemid 32903982)
26. A.I. Ivanov, and J. Christodoulou P.J. Sadler Cisplatin binding sites on human albumin J. Biol. Chem. 273 1998 14721 14730 (Pubitemid 28272756)
27. K.J. Barnham, and M.I. Djuran P.J. Sadler Ring-opened adducts of the anticancer drug carboplatin with sulfur amino acids Inorg. Chem. 35 1996 1065 1072 (Pubitemid 126460616)
28. E.L.M. Lempers, and J. Reedijk Interactions of platinum amine compounds with sulfur-containing biomolecules and DNA fragments A.G. Sykes, Advances in Inorganic Chemistry 1991 Academic Press New York 175 217
29. Z. Chval, and M. Sip Pentacoordinated transition states of cisplatin hydrolysis - ab initio study J. Mol. Struct. THEOCHEM 532 2000 59 68
30. J.V. Burda, M. Zeizinger, and J. Leszczynski Hydration process as an activation of trans- and cisplatin complexes in anticancer treatment. DFT and ab initio computational study of thermodynamic and kinetic parameters J. Comput. Chem. 26 2005 907 914 (Pubitemid 40860394)
31. M. Pavelka, M.F.A. Lucas, and N. Russo On the hydrolysis mechanism of the second-generation anticancer drug carboplatin Chemistry 13 2007 10108 10116
32. M.F.A. Lucas, and M. Pavelka N. Russo Neutral and acidic hydrolysis reactions of the third generation anticancer drug oxaliplatin J. Phys. Chem. B 113 2009 831 838
33. M.E. Alberto, and M.F.A. Lucas N. Russo The second-generation anticancer drug Nedaplatin: a theoretical investigation on the hydrolysis mechanism J. Phys. Chem. B 113 2009 14473 14479
34. J.K.-C. Lau, and D.V. Deubel Hydrolysis of the anticancer drug cisplatin: pitfalls in the interpretation of quantum chemical calculations J. Chem. Theory Comput. 2 2005 103 106
35. T. Zimmermann, and J.V. Burda Reactions of cisplatin with cysteine and methionine at constant pH; a computational study Dalton Trans. 39 2010 1295 1301
36. Y. Mantri, S.J. Lippard, and M.-H. Baik Bifunctional binding of cisplatin to DNA: why does cisplatin form 1,2-intrastrand cross-links with ag but not with GA? J. Am. Chem. Soc. 129 2007 5023 5030 (Pubitemid 46651381)
37. M.-H. Baik, R.A. Friesner, and S.J. Lippard Theoretical study of cisplatin binding to purine bases: why does cisplatin prefer guanine over adenine? J. Am. Chem. Soc. 125 2003 14082 14092 (Pubitemid 37420913)
38. M.E. Alberto, V. Butera, and N. Russo Which one among the Pt-containing anticancer drugs more easily forms monoadducts with G and A DNA bases? A comparative study among oxaliplatin, nedaplatin, and carboplatin Inorg. Chem. 50 2011 6965 6971
39. S. Sharma, and P. Gong S.G. Chaney Molecular dynamic simulations of cisplatin- and oxaliplatin-d(GG) intrastand cross-links reveal differences in their conformational dynamics J. Mol. Biol. 373 2007 1123 1140 (Pubitemid 47539475)
40. E.D. Scheeff, J.M. Briggs, and S.B. Howell Molecular modeling of the intrastrand guanine-guanine DNA adducts produced by cisplatin and oxaliplatin Mol. Pharmacol. 56 1999 633 643 (Pubitemid 29406890)
41. M.-A. Elizondo-Riojas, and J. Kozelka Unrestrained 5 ns molecular dynamics simulation of a cisplatin-DNA 1,2-GG adduct provides a rationale for the NMR features and reveals increased conformational flexibility at the platinum binding site J. Mol. Biol. 314 2001 1227 1243 (Pubitemid 34073083)
42. S.K.C. Elmroth, and S.J. Lippard Platinum binding to d(GpG) target sequences and phosphorothioate linkages in DNA occurs more rapidly with increasing oligonucleotide length J. Am. Chem. Soc. 116 1994 3633 3634
43. N.J. Wheate, and J.G. Collins Multi-nuclear platinum complexes as anti-cancer drugs Coord. Chem. Rev. 241 2003 133 145
44. Y. Wang, N. Farrell, and J.D. Burgess Direct evidence for preassociation preceding covalent binding in the reaction of cis-[Pt(NH3)2(H2O)2]2+ with surface immobilized oligonucleotides J. Am. Chem. Soc. 123 2001 5576 5577 (Pubitemid 32888528)
45. D.A. Case AMBER 11 2010 University of California San Francisco
46. V. Hornak, and R. Abel C. Simmerling Comparison of multiple Amber force fields and development of improved protein backbone parameters Proteins. Struct. Func. Bioinform. 65 2006 712 725 (Pubitemid 44583220)
47. T.E. Cheatham 3rd, P. Cieplak, and P.A. Kollman A modified version of the Cornell et al. force field with improved sugar pucker phases and helical repeat J. Biomol. Struct. Dyn. 16 1999 845 862 (Pubitemid 29157655)
48. A. Pérez, and I. Marchán M. Orozco Refinement of the AMBER force field for nucleic acids: improving the description of α/γ conformers Biophys. J. 92 2007 3817 3829 (Pubitemid 46910569)
49. S. Yao, J.P. Plastaras, and L.G. Marzilli A molecular mechanics AMBER-type force field for modeling platinum complexes of guanine derivatives Inorg. Chem. 33 1994 6061 6077
50. J. Wang, and R.M. Wolf D.A. Case Development and testing of a general amber force field J. Comput. Chem. 25 2004 1157 1174
51. W.L. Jorgensen, and J. Chandrasekhar M.L. Klein Comparison of simple potential functions for simulating liquid water J. Chem. Phys. 79 1983 926 935
52. J. Wang, and R.M. Wolf D.A. Case Junmei Wang, Romain M. Wolf, James W. Caldwell, Peter A. Kollman, and David A. Case, "Development and testing of a general amber force field" Journal of Computational Chemistry(2004) 25(9) 1157-1174 J. Comput. Chem. 26 2005 114
53. D. Bhattacharyya, and S. Ramachandran S.G. Chaney Flanking bases influence the nature of DNA distortion by platinum 1,2-intrastrand (GG) cross-links PLOS ONE 6 2011 e23582
54. P.M. Takahara, and A.C. Rosenzweig S.J. Lippard Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin Nature 377 1995 649 652
55. J.-P. Ryckaert, G. Ciccotti, and H.J.C. Berendsen Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes J. Comput. Phys. 23 1977 327 341
56. S. Miyamoto, and P.A. Kollman Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models J. Comput. Chem. 13 1992 952 962
57. T. Darden, D. York, and L. Pedersen Particle mesh Ewald: an N log(N) method for Ewald sums in large systems J. Chem. Phys. 98 1993 10089 10092
58. H.J.C. Berendsen, and J.P.M. Postma J.R. Haak Molecular dynamics with coupling to an external bath J. Chem. Phys. 81 1984 3684 3690
59. H. Okumura, E. Gallicchio, and R.M. Levy Conformational populations of ligand-sized molecules by replica exchange molecular dynamics and temperature reweighting J. Comput. Chem. 31 2010 1357 1367
60. D.-A. Silva, and G.R. Bowman X. Huang A role for both conformational selection and induced fit in ligand binding by the LAO protein PLOS Comput. Biol. 7 2011 e1002054
61. J.H. Prinz, and H. Wu F. Noé Markov models of molecular kinetics: generation and validation J. Chem. Phys. 134 2011 174105
62. M. Senne, and B. Trendelkamp-Schroer F. Noé EMMA: A software package for Markov model building and analysis J. Chem. Theory Comput. 8 2012 2223 2238
63. A. Eastman The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes Pharmacol. Amp. Ther. 34 1987 155 166 (Pubitemid 17149009)
64. S.E. Sherman, and D. Gibson S.J. Lippard X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2(d(pGpG))] Science 230 1985 412 417 (Pt(NH3)2(d(pGpG))) (Pubitemid 16192555)
65. A.M.J. Fichtinger-Schepman, and J.L. van der Veer J. Reedijk Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation Biochemistry 24 1985 707 713
66. Shaw, D. E., M. M. Deneroff,., S. C. Wang. 2007. Anton, a special-purpose machine for molecular dynamics simulation. Proc. 34th Inter. Symp. Computer Arch., ACM, 34th, San Diego, CA:. 1-12.
67. J.D. Owens, and D. Luebke T.J. Purcell A survey of general-purpose computation on graphics hardware Comput. Graph. Forum 26 2007 80 113 (Pubitemid 46481097)
68. I. Buch, and M.J. Harvey G. De Fabritiis High-throughput all-atom molecular dynamics simulations using distributed computing J. Chem. Inf. Model. 50 2010 397 403
69. P.A. Kollman, and I. Massova T.E. Cheatham 3rd Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models Acc. Chem. Res. 33 2000 889 897 (Pubitemid 32056774)
70. N. Singh, and A. Warshel Absolute binding free energy calculations: on the accuracy of computational scoring of protein-ligand interactions Proteins. Struct. Func. Bioinform. 78 2010 1705 1723
71. C. Jarzynski Nonequilibrium equality for free energy differences Phys. Rev. Lett. 78 1997 2690 2693 (Pubitemid 127655287)
72. P.M. Takahara, C.A. Frederick, and S.J. Lippard Crystal structure of the anticancer drug cisplatin bound to duplex DNA J. Am. Chem. Soc. 118 1996 12309 12321 (Pubitemid 27006798)
73. R. Lavery, and M. Moakher K. Zakrzewska Conformational analysis of nucleic acids revisited: Curves+ Nucleic Acids Res. 37 2009 5917 5929
74. S. Arai, and T. Chatake N. Niimura Complicated water orientations in the minor groove of the B-DNA decamer d(CCATTAATGG)2 observed by neutron diffraction measurements Nucleic Acids Res. 33 2005 3017 3024 (Pubitemid 41511239)
75. M. Chaplin Do we underestimate the importance of water in cell biology? Nat. Rev. Mol. Cell Biol. 7 2006 861 866 (Pubitemid 44627479)
76. G.Y. Park, and J.J. Wilson S.J. Lippard Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile Proc. Nat. Acad. Sci. 2012 10.1073/pnas.1207670109
77. X. Wang, and Z. Guo Targeting and delivery of platinum-based anticancer drugs Chem. Soc. Rev. 42 2013 202 224
78. N. Graf, and D.R. Bielenberg S.J. Lippard α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug ACS Nano 6 2012 4530 4539
79. A. Eastman Reevaluation of interaction of cis-dichloro(ethylenediamine) platinum(II) with DNA Biochemistry 25 1986 3912 3915 (Pubitemid 16042519)
80. J. Raber, C. Zhu, and L.A. Eriksson Theoretical study of cisplatin binding to DNA: the importance of initial complex stabilization J. Phys. Chem. B 109 2005 11006 11015 (Pubitemid 40850250)
81. M. Guéroult, and O. Boittin B. Hartmann Mg2+ in the major groove modulates B-DNA structure and dynamics PLOS ONE 7 2012 e41704
82. B. Spingler, D.A. Whittington, and S.J. Lippard 2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex Inorg. Chem. 40 2001 5596 5602 (Pubitemid 32999342)
83. W. Humphrey, A. Dalke, and K. Schulten VMD: visual molecular dynamics J. Mol. Graph. 14 1996 33 38 27-28 (Pubitemid 26152973)
84. Schrödinger, L. 2011. Jaguar, version 7.8. New York.
85. Schrödinger, L. 2008. QSite 5.0. New York.
86. Research, D. E. S. 2008. Desmond Molecular Dynamics System, version 2.X. New York.
87. M.J. Frisch, and G.W. Trucks T.V. Jr Gaussian 03 (Revision C.2) 2004 Gaussian, Inc. Pittsburgh
88. Reference deleted in proof.
89. Reference deleted in proof.
90. Reference deleted in proof.
91. D. Sitkoff, K.A. Sharp, and B. Honig Accurate calculation of hydration free energies using macroscopic solvent models J. Phys. Chem. 98 1994 1978 1988
92. M. Bonomi, and D. Branduardi M. Parrinello PLUMED: a portable plugin for free-energy calculations with molecular dynamics Comput. Phys. Commun. 180 2009 1961 1972